Mesoblast (MEOBF) Current Assets (2014 - 2026)
Mesoblast's (MEOBF) quarterly Current Assets came in at $197.5 million in Q2 2026, down 3.36% year-over-year from $204.4 million in Q2 2025, and down 2.47% quarter-over-quarter from $202.5 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Current Assets (2014 - 2026) Analysis & Trends
Mesoblast has disclosed Current Assets across 13 years of filings, most recently posting $197.5 million for Q2 2026.
- In Q2 2026, Current Assets fell 3.36% year-over-year to $197.5 million; the TTM figure through Jun 2026 stood at $197.5 million (down 3.36% YoY), while the FY2026 annual figure was $197.5 million, down 3.36% from the prior year.
- Current Assets came in at $197.5 million for Q2 2026 at Mesoblast, down from $202.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $204.4 million in Q2 2025 to a low of $61.4 million in Q1 2023.
- Average Current Assets over 5 years is $109.8 million, with a median of $85.8 million recorded in 2023.
- Year-over-year, Current Assets plunged 52.89% in 2022 and soared 190.59% in 2025.
- Over 5 years, Current Assets stood at $78.1 million in 2022, then advanced by 8.99% to $85.2 million in 2023, then dropped by 18.17% to $69.7 million in 2024, then surged by 190.59% to $202.5 million in 2025, then slipped by 2.47% to $197.5 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $197.5 million in Q2 2026, $202.5 million in Q4 2025, and $204.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.06 Bn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 2.37 Bn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 464.26 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 1.23 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 834.27 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 1.18 Bn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 134.38 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 2.22 Bn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 264.73 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 197.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 197.49 Mn |
| Dec 31, 2025 | 202.48 Mn |
| Jun 30, 2025 | 204.35 Mn |
| Dec 31, 2024 | 69.68 Mn |
| Jun 30, 2024 | 86.46 Mn |
| Dec 31, 2023 | 85.15 Mn |
| Jun 30, 2023 | 81.66 Mn |
| Mar 31, 2023 | 61.37 Mn |
| Dec 31, 2022 | 78.13 Mn |
| Sep 30, 2022 | 92.96 Mn |
| Jun 30, 2022 | 69.84 Mn |
| Mar 31, 2022 | 88.13 Mn |
| Dec 31, 2021 | 108.80 Mn |
| Sep 30, 2021 | 126.22 Mn |
| Jun 30, 2021 | 148.23 Mn |
| Mar 31, 2021 | 169.77 Mn |
| Dec 31, 2020 | 90.46 Mn |
| Sep 30, 2020 | 115.74 Mn |
| Jun 30, 2020 | 136.55 Mn |
| Mar 31, 2020 | 69.39 Mn |